Source: Annual Congress 2006 - Screening, diagnosis, staging, prognosis, biological features
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. A. Bazyka, L. I. Shvayko (Kiev, Ukraine). Lung resistance-related protein in lung cancer and lung lesions in Hodgkin disease. Eur Respir J 2006; 28: Suppl. 50, 590

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer and interstitial lung disease Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer Source: International Congress 2016 – Orphan diseases I Year: 2016 A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Bilateral lung cancer with COPD or metastatic disease Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology Year: 2016 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Siphonage lung disease Source: Virtual Congress 2020 – Respiratory critical care Year: 2020 Pancreatic polypeptide is increased in patients with advanced malignant disease including lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 232s Year: 2002 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001 Aerosoltherapy in lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020 Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Fitness before lung resection in lung cancer patients Source: CME Online 2010 Year: 2010 Interstitial lung diseases and lung cancer Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Do cavitating non-small cell lung cancer patients have a more aggressive disease? Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006 Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006 A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Lung function predicts lung cancer Source: Eur Respir J 2010; 35: 1421-1422 Year: 2010 Connective tissue disease-related interstitial lung disease and lung cancer Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018